EKSO BIONICS HOLDING (OTCBB:EKSO), a leading robotic exoskeleton company is pleased to announce that it has received a third contract from SOCOM (U.S. Special Operations Command). The primary objective of this contract is to finish the next phase of Tactical Assault Light Operator Suit project.
As per the reports, Ekso Bionics will work on the next phase of the TALOS project after successful completion of the previous two.
Insights on The Announcement:
The latest phase of the project will consist developing an upper extremity part for TALOS Mk III. In addition to this contract, Ekso Bionics has also received new grants from US Patent Office. Reports claim that US Patent Office has decided to approve three new patents after witnessing quality work from the company on DARPA and other related government projects.
It was 2014 when the U.S. Special Operations Command made public its intentions to come up with a wearable uniform that provides excellent mobility, protection and superhuman capabilities. SOCOM wanted to design such uniforms for their Special Operations Forces that remain in the field for most of the time and face unexpected life-threatening risks.
In the same direction, SOCOM wants to move further with the development of exoskeleton that will offer all the soldiers ballistic protection from head‐to‐toe without affecting fluid movements.
Management Call:
The senior management team of the company is delighted to share this news with all the shareholders. According to Russ Angold, Co-Founder, Ekso Bionics, it’s a proud moment for the company to have a wonderful relation with SOCOM and get a chance to add value to TALOS project. The commitment to push the technology to a higher level and the second to none expertise in exoskeletons give Ekso Bionics advantage over its rivals.
The current association with SOCOM will work as a base for the future commercial projects focusing on upper extremity exoskeletons and help the company writing a new success story in days to come.
